FDA grants Breakthrough Therapy Designation to Legacy Healthcare's CINAINU (LH-8)
Racura Oncology receives approval for RC220 trial to proceed to higher dose
Blue Lake Biotechnology reports interim data from Phase 1/2a paediatric clinical trial of BLB201
ArkBio reports FDA clearance of IND application for AK0406
Enodia Therapeutics partners with Pfizer on Sec61-targeting drug development
TWINBIRD launches portable freezer targeting dry-ice-free research cold chains
Solvonis signs Portugal agreement to assess European expansion of Phase 3 alcohol addiction trial
Bristol Myers Squibb reports positive Phase 3 results for RYZ101 in neuroendocrine tumours
Camurus receives Canadian approval for Oczyesa XR for acromegaly
Akeso reports first patient dosed in Phase III study of cadonilimab in colon cancer
Glaukos reports positive Phase 4 results for iDose TR with cataract surgery
Medincell partner Teva secures FDA approval for monthly schizophrenia treatment
Alumis reports new Phase 3 data showing sustained skin clearance with envudeucitinib